Kallidinogenase - Techpool Bio-Pharma

Drug Profile

Kallidinogenase - Techpool Bio-Pharma

Alternative Names: Kailikang; Urinary Kallidinogenase for Injection; Urinary kallikrein

Latest Information Update: 07 Oct 2015

Price : $50

At a glance

  • Originator Techpool Bio-Pharma
  • Class Vascular disorder therapies; Vasodilators
  • Mechanism of Action Enzyme replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Cerebral infarction

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top